Company intelligence / Profile preview
VasoDynamics
Stevenage, England, United Kingdomvasodynamics.co.uk ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Phase 1
01
Overview
NG11-2 has completed Phase 1b clinical trials for radiation-induced oral mucositis. NG12-1 has obtained Proof-of-Concept with a well-tolerated safety profile and statistically significant efficacy in an Investigator-led Phase-IIa trial.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Pharmaceutical formulations
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on VasoDynamics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VasoDynamics.